Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer

Fig. 3

Stratification for NLR in different tumor volume groups. Patients with elevated NLR (> = 4.68) showed a significantly reduced recurrence-free survival in all tumor volume groups as well as inferior overall survival in the intermediate and high-tumor volume group (a-b: <15 cm3, c-d: 15-70 cm3, e-f: >70 cm3). NLR resulted in an additional statistically significant prognostic differentiation of the volumetric cohorts with respect to RFS and OS rates (except of the ‘small tumor volume’ cohort with only 4 events, Fig. 3b)

Back to article page
\